BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 308846)

  • 1. Subpopulations of human T lymphocytes. IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome.
    Gupta S; Safai B; Good RA
    Cell Immunol; 1978 Aug; 39(1):18-26. PubMed ID: 308846
    [No Abstract]   [Full Text] [Related]  

  • 2. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
    Gupta S; Safai B; Edelson R; Parrott D; Good R
    Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
    [No Abstract]   [Full Text] [Related]  

  • 3. Functionally distinct subpopulations of human T lymphocytes--a review.
    Gupta S
    Clin Bull; 1978; 8(3):100-6. PubMed ID: 311716
    [No Abstract]   [Full Text] [Related]  

  • 4. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
    Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
    J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
    Furue M; Kadono T
    J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CD24-related epitopes in mycosis fungoides/Sézary syndrome: a potential marker for circulating Sézary cells.
    Pirruccello SJ; Lang MS
    Blood; 1990 Dec; 76(11):2343-7. PubMed ID: 1701668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG anti-50 kd lymphocyte membrane peptide antibody in patients with Sézary syndrome.
    D'Ambra-Cabry K; Tharp MD; Jagasothy BV; Deng JS
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):777-80. PubMed ID: 8632073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
    Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T
    Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch tests in Sézary syndrome and mycosis fungoides.
    Shupp DL; Winkelmann RK
    Contact Dermatitis; 1985 Sep; 13(3):180-5. PubMed ID: 4053598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More about the T-cell receptor V beta repertoire usage in mycosis fungoides/Sézary syndrome.
    Bachelez H; Gorochov G
    Br J Dermatol; 1995 Jun; 132(6):1017-8. PubMed ID: 7662555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mycosis fungoides and monoclonal dysglobulinemia].
    Gianadda B; Robart S; Brutzkus A; Perrot H
    Ann Dermatol Venereol; 1980; 107(1-2):71-4. PubMed ID: 6768335
    [No Abstract]   [Full Text] [Related]  

  • 15. The Langerhans cell.
    Thiers BH
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):519-22. PubMed ID: 6176601
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human malignant T cells capable of inducing an immunoglobulin class switch.
    Mayer L; Posnett DN; Kunkel HG
    J Exp Med; 1985 Jan; 161(1):134-44. PubMed ID: 2981951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T gamma-lymphocytosis: a lymphoproliferative disease or reactive state].
    Zaritskiĭ AIu; Pozniak EI; Tsveĭbakh AS; Simbirtseva NIu; Ivasenko IN
    Vopr Onkol; 1986; 32(4):11-25. PubMed ID: 3518236
    [No Abstract]   [Full Text] [Related]  

  • 19. Defective monocyte chemotaxis in mycosis fungoides: lack of essential helper lymphocytes.
    Norris DA; Perez RE; Golitz LE; Seitz LE; Weston WL
    Cancer; 1979 Jul; 44(1):124-30. PubMed ID: 313241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosette-formation with mouse erythrocytes: VI. T, B, and third population lymphoid cells in mycosis fungoides and effect of leukopheresis.
    Gupta S; Safai B; Good RA
    Am J Hematol; 1978; 4(2):133-40. PubMed ID: 150227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.